Formulation and Evaluation of Oral Mucoadhesive Microspheres of Ofloxacin for Peptic Ulcer Use

Authors

  • Rohitas Deshmukh Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India https://orcid.org/0000-0002-8962-6821
  • Ranjit K. Harwansh Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India
  • Mahendra Prajapati Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India
  • Bhavana Sharma Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India

DOI:

https://doi.org/10.48048/tis.2023.5751

Keywords:

Microsphere, Swelling index, Peptic ulcer, Factorial design, Gastro-retentive system, Entrapment efficiency

Abstract

A peptic ulcer is a disease that affects the stomach lining caused by Helicobacter pylori. The present research aimed to formulate and evaluate the mucoadhesive microsphere of ofloxacin for the effective and safe treatment of peptic ulcers. The mucoadhesive microspheres were developed using natural polymers like Guar gum, Sodium alginate, and Chitosan using the emulsification cross-linking method. A total of 8 batch formulations were prepared using 23 full factorial designs. The prepared microspheres were evaluated various parameters such as % yield, entrapment efficiency, drug release study, in vitro wash-off test, optimization was done by the design of expert which was further subjected to statistical analysis that was kinetic release mechanism, compatibility studies were performed such as FTIR and DSC. Using factorial design 23 for the maximum possible formulation, the optimized formulation was found to be F5 in terms of better release for a longer time and with better mucoadhesive properties on the use of guar gum, sodium alginate, and chitosan in ratio 1:1:2. Second-order polynomial equations were derived for absorbing responses after the application of ANOVA, after omitting the non-significant (p ≥ 0.05) coefficients. %CDR 56.10 % for an extended period of 8 h, % EE exhibited 86.25±1.16. The sustained release activity of F5 might be due to the adhesion of the polymer to the gastric mucosa for more extended periods of 71 % to 8 h. it is also favoured by the suitable particle size of the optimized formulation. The result indicated that the prepared mucoadhesive microspheres can release the ofloxacin in sustained manner and helps in the management of peptic ulcer.

HIGHLIGHTS

  • Ofloxacin loaded mucoadhesive microsphere was prepared for treatment of peptic ulcer
  • The mucoadhesive microspheres were developed using natural polymers
  • A total of 8 batch formulations were prepared using 23 full factorial designs
  • Drug release from the optimized microsphere was 71 % to 8 h
  • The developed microsphere can effectively deliver the drug in stomach part


GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

L Kuna, J Jakab, R Smolic, N Raguz-Lucic, A Vcev and M Smolic. Peptic ulcer disease: A brief review of conventional therapy and herbal treatment options. J. Clin. Med. 2019; 8, 179.

D Majumdar, J Bebb and J Atherton. Helicobacter pylori infection and peptic ulcers. Medicine 2011; 39, 154-61.

RK Harwansh and R Deshmukh. Formulation and evaluation of sodium alginate and guar gum based glycyrrhizin loaded mucoadhesive microspheres for management of peptic ulcer. 2021; 55, 728-37.

S Baddam, S Bandari and G B Chaithanya. Formulation and evaluation of fast dissolving tablets of ofloxacin by direct compression method. Int. Res. J. Pharm. 2013; 4, 79-86.

RH Drew and HA Gallis. Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. Pharmacotherapy 1988; 8, 35-46.

R Gupta, P Pandey and R Gupta. Miracle of gastroretentive drug delivery systems: approaches for treatment of gastric disorders and their future perspectives. J. Pharm. Res. Int. 2021; 33, 646-66.

Y Murti, KK Agrawal, BC Semwal and S Singh. Lead phytomolecules for gastroprotective drug development. J. Adv. Trad. Med. 2022. https://doi.org/10.1007/s13596-022-00633-7

JH Lee, TG Park and HK Choi. Development of oral drug delivery system using floating microspheres. J. Microencapsul. 1999; 16, 715-29.

P Shivanand. Different techniques of formulation and evaluation of mucoadhesive microspheres. Int. J. Pharma Bio Sci. 2010; 1, 1-7.

AK Patel, MK Mishra, J Gupta, S Ghoshal, R Gupta and K Kushwaha. Guar gum-based floating microspheres of repaglinide using 3(2) factorial design: Fabrication, optimization, characterization, and in vivo buoyancy behavior in albino rats. Assay Drug Dev. Tech. 2021; 19, 63-74.

A Thummar, CR Kyada, R Kalyanvat and B Shreevastva. A review on mucoadhesive microspheres as a novel drug delivery system. 2013; 2, 188-200.

BC Thanoo, MC Sunny and A Jayakrishnan. Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol. 1992; 44, 283-6.

TW Wong, LW Chan, HY Lee and PWS Heng. Release characteristics of pectin microspheres prepared by an emulsification technique. J. Microencapsul. 2002; 19, 511-22.

V Kulkarni, P Kulkarni and APS Keshavayya. Glutaraldehyde‐crosslinked chitosan beads for controlled release of diclofenac sodium. J. Appl. Polym. Sci. 2007; 103, 211-7.

R Deshmukh, RK Harwansh and MA Rahman. Sodium alginate-guar gum and carbopol based methotrexate loaded mucoadhesive microparticles for colon delivery: An in vitro evaluation. Braz. J. Pharm. Sci. 2021; 57, 13.

K Kunchu and R Veera. Albumin microspheres: A unique system as drug delivery carriers for non steroidal anti-inflammatory drugs. Int. J. Pharm. Sci. Rev. Res. 2010; 5, 23-7.

R Hejazi and M Amiji. Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracyline-loaded chitosan microspheres. Int. J. Pharm. 2002; 235, 87-94.

P Gaba, S Singh, M Gaba and GD Gupta. Galactomannan gum coated mucoadhesive microspheres of glipizide for treatment of type 2 diabetes mellitus: In vitro and in vivo evaluation. Saudi. Pharm. J. 2011; 19, 143-52.

ML Amin, T Ahmed and MA Mannan. Development of floating-mucoadhesive microsphere for site specific release of metronidazole. Adv. Pharm. Bull. 2016; 6, 195.

M Negi, V Shukla and T Easwari. Preparation and evaluation of ofloxacin sustained released gastro retentive floating microspheres. 2014; 2, 19-24.

P Arya and K Pathak. Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: Optimization and pharmacokinetics. Int. J. Pharm. 2014; 460, 1-12.

AB Khan and RS Thakur. Formulation and evaluation of mucoadhesive microspheres of tenofovir disoproxil fumarate for intravaginal use. Curr. Drug Deliv. 2014; 11, 112-22.

R Deshmukh and RK Harwansh. Preformulation considerations development and evaluation of mesalamine loaded polysaccharide-based complex mucoadhesive beads for colon targeting. Indian J. Pharm. Educ. Res. 2021; 55, 95-106.

PS Rajinikanth, LN Karunagaran, J Balasubramaniam and B Mishra. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori. Chem. Pharm. Bull. 2008; 56, 1658-64.

MS Ali, V Pandit, M Jain and KL Dhar. Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. J. Adv. Pharm. Tech. Res. 2014; 5, 48-56.

JV Andhariya and DJ Burgess. Recent advances in testing of microsphere drug delivery systems. Expert Opin. Drug Deliv. 2016; 13, 593-608.

RK Malik, P Malik, N Gulati and U Nagaich. Fabrication and in vitro evaluation of mucoadhesive ondansetron hydrochloride beads for the management of emesis in chemotherapy. Int. J. Pharm. Investig. 2013; 3, 42-6.

RA Ishak, GAS Awad, ND Mortada and SAK Nour. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. J. Control. Release 2007; 119, 207-14.

RR Earle, VV Bharathi, LU Ayalasomayajula and AVSK Bhavani. Cross-linked chitosan based stomach specific mucoadhesive microspheres loaded with amoxicillin: Preparation and ex vivo characterization. Int. J. Pharm. Investig. 2020; 10, 59-63.

B Devrim and K Canefe. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: Effect of variables. Acta Pol. Pharm. 2006; 63, 521-34.

M Sharma, P Choudhury and S Dev. Formulation and In-vitro-in-vivo evaluation of alginate-chitosan microspheres of glipizide by ionic gelation method. Asian J. Pharm. Clin. Res. 2017; 10, 385.

BB Horoz, M Kiliçarslan, N Yüksel and T Baykara. Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres. AAPS PharmSciTech 2006; 7, E111-E117.

RC Rowe, PJ Sheskey and ME Quinn. Handbook of pharmaceutical excipients. 6th eds. Pharmaceutical Press, London, 2009, p. 506-9.

A Desai, S Shidhaye and VJ Kadam. Possible use of psyllium husk as a release retardant. Indian J. Pharm. Sci. 2007; 69, 206.

SA Ziai, B Larijani, S Akhoondzadeh, H Fakhrzadeh, A Dastpak, F Bandarian, A Rezai, HN Badi and T Emami. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J. Ethnopharmacol. 2005; 102, 202-7.

Downloads

Published

2023-06-01

How to Cite

Deshmukh, R. ., Harwansh, R. K. ., Prajapati, M. ., & Sharma, B. . (2023). Formulation and Evaluation of Oral Mucoadhesive Microspheres of Ofloxacin for Peptic Ulcer Use. Trends in Sciences, 20(9), 5751. https://doi.org/10.48048/tis.2023.5751